the case of vaccines for human use
new category of biological medicinal products
summary of clinical pharmacology
manufacturing process development characterisation
the case of analytical procedures
subject of a monograph of the european pharmacopoeia
quantitative statement of an active substance
results of the validation studies for critical steps
marketing authorisation in the community
separate from the dossier for marketing authorisation
holder of the marketing authorisation
full dossier to a competent authority
community procedures for the authorisation
the relevant monograph of the european pharmacopoeia
the authorisation of herbal medicinal products
diversity of gene therapy medicinal products
operations of the same type
requirements of the thermal test
